Abbott Laboratories vs. Briacell Therapeutics Corp. Common Shares
ABT
Abbott Laboratories
$105.71 +0.24%
VS BCTXBriacell Therapeutics Corp. Common Shares
$3.45 -1.43%
Abbott Laboratories and Briacell Therapeutics Corp. Common Shares are evenly matched on the factors we track — the better pick depends on what you're optimizing for.
Size & Scale
| ABT | BCTX | |
|---|---|---|
| Market Cap | $182.92 billion | $30.45 million |
| Revenue (TTM) | — | — |
| Net Income (TTM) | — | $-30,976,383 |
ABT leads on 1 of 1 size & scale factors.
Valuation
| ABT | BCTX | |
|---|---|---|
| Price / Book | — | 1.30 |
ABT and BCTX split the valuation factors evenly.
Profitability
| ABT | BCTX | |
|---|---|---|
| Return on Equity | — | -132.33% |
ABT and BCTX split the profitability factors evenly.
Risk & Sentiment
| ABT | BCTX | |
|---|---|---|
| Short Interest | 0.57% | 0.29% |
BCTX leads on 1 of 1 risk & sentiment factors.
Dig deeper: ABT overview, ABT financials, BCTX overview, BCTX financials.
Comparisons use delayed, cached fundamental data and cover only the factors shown. For informational purposes only — not investment advice.